IP Library Assignment 054122/0812
Patent Assignment
Reel/Frame 054122/0812

Change of Name

Recorded: 2020-10-19 Pages: 4
Assignor
SEATTLE GENETICS, INC.
Executed: 2020-10-06
Assignee
SEAGEN INC.
21823 30TH DRIVE SE, BOTHELL, WASHINGTON, 98021
Covered Properties (34)
Pegylated Drug-Linkers for Improved Ligand-Drug Conjugate Pharmacokinetics
Application: 15/029,584 →
Publication: US 2016/0310612
Beta-Glucuronide-Linker Drug Conjugates
Application: 15/463,267 →
Publication: US 2017/0189542
Targeted Delivery of Tertiary Amine-Containing Drug Substances
Application: 15/510,163 →
Publication: US 2017/0247412
Antibody Drug Conjugates (Adc) That Bind to 191P4D12 Proteins
Patent: 48,389 →
Application: 15/697,146 →
Conjugates of Quaternized Tubulysin Compounds
Application: 15/781,244 →
Publication: US 2019/0015517
Cancer Treatment Using 2-Deoxy-2-Fluoro-L-Fucose in Combination with a Checkpoint Inhibitor
Application: 15/781,256 →
Publication: US 2018/0353524
Self-Stabilizing Linker Conjugates
Application: 15/890,252 →
Publication: US 2018/0154011
Intact Mass Determination of Protein Conjugated Agent Compounds
Application: 15/925,639 →
Publication: US 2018/0275137
Antibody Drug Conjugates (Adc) That Bind to 191P4D12 Proteins
Application: 15/943,527 →
Publication: US 2018/0296693
Combinations of Pbd-Based Antibody Drug Conjugates with Bcl-2 Inhibitors
Application: 16/085,460 →
Publication: US 2019/0076549
Process for the Preparation of Pegylated Drug-Linkers and Intermediates Thereof
Application: 16/088,235 →
Publication: US 2019/0388546
Combinations of CD33 Antibody Drug Conjugates with Hypomethylating Agents
Application: 16/093,947 →
Publication: US 2019/0117787
Combination of CD33 Antibody Drug Conjugates with Chemotherapeutic Agents
Application: 16/306,118 →
Publication: US 2019/0134215
Combinations of Pbd-Based Antibody Drug Conjugates with FLT3 Inhibitors
Application: 16/308,225 →
Publication: US 2019/0262354
Drug Conjugates with Self-Stabilizing Linkers Having Improved Physiochemical Properties
Application: 16/324,198 →
Publication: US 2019/0167806
Targeted Delivery of Nicotinamide Adenine Dinucleotide Salvage Pathway Inhibitors
Application: 16/343,140 →
Publication: US 2019/0314519
Bivalent Antibodies Masked by Coiled Coils
Application: 16/348,481 →
Publication: US 2019/0352428
Camptothecin Peptide Conjugates
Application: 16/376,302 →
Publication: US 2019/0343828
Methods and Compositions for Making Antibodies and Antibody Derivatives with Reduced Core Fucosylation
Application: 16/414,633 →
Publication: US 2019/0276796
Methods of Inhibition of Protein Fucosylation in Vivo Using Fucose Analogs
Application: 16/452,160 →
Publication: US 2020/0061091
Multi-Drug Antibody Drug Conjugates
Application: 16/463,541 →
Publication: US 2020/0129639
Cysteine Mutated Antibodies for Conjugation
Application: 16/483,025 →
Publication: US 2022/0175947
Process for the Preparation of Glucuronide Drug-Linkers and Intermediates Thereof
Application: 16/497,133 →
Publication: US 2020/0222553
Variant Target Binding Agents and Uses Thereof
Application: 16/525,131 →
Publication: US 2020/0062857
Preparing Antibodies from Cho Cell Cultures for Conjugation
Application: 16/573,154 →
Publication: US 2020/0063180
Selective Reduction of Proteins
Application: 16/580,290 →
Publication: US 2020/0115438
Quaternized Nicotinamide Adenine Dinucleotide Salvage Pathway Inhibitor Conjugates
Application: 16/608,748 →
Publication: US 2020/0197524
T Cells with Reduced Surface Fucosylation and Methods of Making and Using the Same
Application: 16/616,928 →
Publication: US 2020/0149082
Process for the Preparation of Tubulysins and Intermediates Thereof
Application: 16/645,369 →
Publication: US 2020/0297864
Antibody Drug Conjugates (Adc) That Bind to 158P1D7 Proteins
Application: 16/866,408 →
Publication: US 2021/0095043
CD48 Antibodies and Conjugates Thereof
Application: 16/892,529 →
Publication: US 2020/0289661
Hydrophobic Auristatin F Compounds and Conjugates Thereof
Application: 16/968,749 →
Publication: US 2021/0008099
Glypican 3 Antibodies and Conjugates Thereof
Application: 16/970,095 →
Publication: US 2021/0361776
Selective Drug Release from Internalized Conjugates of Biologically Active Compounds
Application: 17/026,048 →
Publication: US 2021/0138077
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 10, 2019
From: JEFFREY, SCOTT; LYSKI, RYAN; RYAN, MAUREEN; COCHRAN, JULIA
To: SEATTLE GENETICS, INC.
Reel/Frame 048846/0577 →
Assignment of Assignor's Interest Aug 7, 2019
From: TRANG, VIVIAN; LEVENGOOD, MATTHEW R.; SENTER, PETER
To: SEATTLE GENETICS, INC.
Reel/Frame 049988/0755 →
Assignment of Assignor's Interest Nov 26, 2019
From: AGENSYS, INC.
To: AGENSYS, INC.; SEATTLE GENETICS, INC.
Reel/Frame 051125/0122 →
Assignment of Assignor's Interest Nov 26, 2019
From: SATPAYEV, DAULET; MORRISON, ROBERT KENDALL; MORRISON, KAREN JANE MEYRICK; GUDAS, JEAN
To: AGENSYS, INC.
Reel/Frame 051125/0085 →
Assignment of Assignor's Interest Nov 26, 2019
From: AGENSYS, INC.
To: AGENSYS, INC.; SEATTLE GENETICS, INC.
Reel/Frame 051125/0096 →
Assignment of Assignor's Interest Nov 26, 2019
From: SATPAYEV, DAULET; MORRISON, ROBERT KENDALL; MORRISON, KAREN JANE MEYRICK; GUDAS, JEAN
To: AGENSYS, INC.
Reel/Frame 051125/0114 →
Assignment of Assignor's Interest Dec 19, 2019
From: LYON, ROBERT; DORONINA, SVETLANA O.; BOVEE, TIMOTHY
To: SEATTLE GENETICS INC.
Reel/Frame 051328/0465 →
Assignment of Assignor's Interest Dec 19, 2019
From: VALLIERE-DOUGLASS, JOHN FAY; SALAS, OSCAR
To: SEATTLE GENETICS INC.
Reel/Frame 051371/0523 →
Assignment of Assignor's Interest Sep 3, 2020
From: MOQUIST, PHILIP
To: SEATTLE GENETICS, INC.
Reel/Frame 053689/0558 →
Assignment of Assignor's Interest Sep 3, 2020
From: NEUMANN, CHRISTOPHER SCOTT; OLIVAS, KATHLEEN
To: SEATTLE GENETICS, INC.
Reel/Frame 053689/0868 →
Change of Name Oct 16, 2020
From: SEATTLE GENETICS, INC.
To: SEAGEN INC.
Reel/Frame 054102/0821 →